Developing New Prognostic Scores In

Sally F. Barrington, MBBS, MSc, FRCP, FRCR, MD, King's College London, London, UK, summarizes a

Alexandros Spyridonidis, MD, University of Patras, Patras, Greece, comments on the

In this video, Maria Julia Montoro, MD, PhD, Vall d'Hebron University Hospital, Barcelona, Spain, briefly discusses the ...

Barbara Eichhorst, Critical Assessment and New Development of Prognostic Scoring Systems

Claudio Cerchione, MD, PhD, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy, ...

This content is intended for US HCPs only. This video is part of the Myelofibrosis and Strategies for Disease Management: Key ...

Klaus Schmierer, MB BS, PhD, FRCP, Queen Mary University of London & The Royal London Hospital of Barts Health NHS Trust, ...

Susan Halabi, PhD, FSCT, FASA, FASCO, Duke Cancer Institute, Durham, NC, describes the

As Sei Lee notes, the argument for

Neal Shore, MD, Philippa Cheetham, MD, and Michael Williams, MD, discuss the

Elizabeth Griffiths, MD.

Prof Moorman speaks with ecancer at EHA 23 about the

Jennifer Frontera, MD,

... MD, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, discusses the

Panelists Ezra Cohen, MD; Viktor Grünwald, MD; Tanguy Y. Seiwert, MD; and Kevin Harrington, MD, PhD, provide insight on ...

Morie Gertz, MD, MACP, Mayo Clinic, Rochester, MN, discusses the use of measurable residual disease (MRD) negativity as a ...

Dr. Carraro, a neurologist and MS Specialist at Piedmont HealthCare Lake Norman Neurology discusses the

Watch on LabRoots at: http://labroots.com/user/webinars/details/id/84 With the rapid rise in the number of therapeutic options for ...

Jasmin Bahlo, PhD of University of Cologne, Cologne, Germany gives an overview CLL-IPI and its use in chronic lymphocytic ...

Adrian Mosquera Orgueira, MD, PhD, Complejo Hospitalario Universitario de Santiago de Compostela (CHUS), Santiago de ...